Synaptogenix (SNPX) Stock Statistics & Valuation Metrics

Synaptogenix has a market cap or net worth of $4.86M. The enterprise value is ―.

Synaptogenix has 1,389,815 shares outstanding. The number of shares has decreased by -2.65% in one year.

Synaptogenix’s return on equity (ROE) is 2.31 and return on invested capital (ROIC) is 0.00%.

The current PE Ratio of Synaptogenix is <0.01. Synaptogenix’s PEG ratio is <0.01.

In the last 12 months, Synaptogenix had revenue of 0.00 and earned 13.56T in profits. Earnings per share was 10.99M.

In the last 12 months, operating cash flow was -4.78M and capital expenditures 0.00, giving a free cash flow of -4.78M billion.

Synaptogenix pays an annual dividend of ―, resulting in a dividend yield of ―

Synaptogenix upcoming earnings date is ―, TBA Not Confirmed.

Synaptogenix as a current ratio of 17.47, with Debt / Equity ratio of 0.00%

In the past 12 months, Synaptogenix has paid -789.91B in taxes.

Synaptogenix EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 3.62.

Synaptogenix has $22.07M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$22.07M billion.

Gross margin is 61.79%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Synaptogenix is ―, which is 11.43% higher than the current price. The consensus rating is ―